Skip to main content
Fig. 4 | Arthritis Research & Therapy

Fig. 4

From: Predictors of remission with etanercept-methotrexate induction therapy and loss of remission with etanercept maintenance, reduction, or withdrawal in moderately active rheumatoid arthritis: results of the PRESERVE trial

Fig. 4

Strongest sets of predictors of loss of Disease Activity Score based on a 28-joint count (DAS28) remission (a), DAS28 remission plus change in DAS28 ≥ 0.6 (b), Simplified Disease Activity Index (SDAI) remission (c), and Clinical Disease Activity Index (CDAI) remission (d) in the double-blind period by treatment group using stepwise models. CI, confidence interval; CRP, C-reactive protein; ESR, erythrocyte sedimentation rate; HAQ, health assessment questionnaire; PGA, physician global assessment; PtGA, patient global assessment; RF, rheumatoid factor; SJC, swollen joint count; ULN, upper limit of normal; VAS, visual analog scale

Back to article page